Biohaven Current Ratio 2016-2022 | BHVN

Biohaven current ratio from 2016 to 2022. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Biohaven Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2022-09-30 $0.08B $0.03B 2.83
2022-06-30 $1.17B $0.67B 1.75
2022-03-31 $1.17B $0.58B 2.03
2021-12-31 $0.10B $0.04B 2.26
2021-09-30 $0.94B $0.46B 2.04
2021-06-30 $0.67B $0.40B 1.67
2021-03-31 $0.90B $0.40B 2.28
2020-12-31 $0.60B $0.28B 2.17
2020-09-30 $0.71B $0.22B 3.26
2020-06-30 $0.36B $0.17B 2.18
2020-03-31 $0.47B $0.12B 3.89
2019-12-31 $0.00B 0.00
2019-09-30 $0.42B $0.05B 8.96
2019-06-30 $0.47B $0.05B 10.62
2019-03-31 $0.23B $0.02B 9.60
2018-12-31 $0.27B $0.02B 13.94
2018-09-30 $0.18B $0.02B 11.99
2018-06-30 $0.23B $0.01B 17.84
2018-03-31 $0.12B $0.02B 6.80
2017-12-31 $0.14B $0.01B 14.49
2017-09-30 $0.18B $0.02B 8.12
2017-06-30 $0.21B $0.02B 11.91
2017-03-31 $0.05B $0.02B 3.44
2016-12-31 $0.02B $0.01B 3.03
2016-09-30 $0.00B 0.00
2016-06-30 $0.00B 0.00
2016-03-31 $0.00B 0.00
2015-12-31 $0.00B $0.00B 5.74
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.282B $0.463B
Biohaven Ltd. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing therapies for patients with debilitating neurological and neuropsychiatric diseases principally in the United States. Biohaven Ltd., formerly known as BIOHAVEN PHARM, is based in New Haven, Connecticut.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $154.040B 9.40
GSK (GSK) United Kingdom $72.263B 9.00
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.195B 19.11
Ginkgo Bioworks Holdings (DNA) United States $3.764B 0.00
Myovant Sciences (MYOV) United Kingdom $2.614B 0.00
Arcus Biosciences (RCUS) United States $1.675B 25.14
Emergent Biosolutions (EBS) United States $0.672B 5.28
ADC Therapeutics SA (ADCT) Switzerland $0.388B 0.00
Ambrx Biopharma (AMAM) United States $0.075B 0.00
Enzo Biochem (ENZ) United States $0.069B 0.00
Gelesis Holdings (GLS) United States $0.026B 0.00
SQZ Biotechnologies (SQZ) United States $0.024B 0.00